nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.0519	0.0683	CcSEcCtD
Finasteride—Injury—Riluzole—amyotrophic lateral sclerosis	0.0453	0.0597	CcSEcCtD
Finasteride—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0449	0.0592	CcSEcCtD
Finasteride—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.0414	0.0544	CcSEcCtD
Finasteride—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0381	0.0501	CcSEcCtD
Finasteride—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.0377	0.0496	CcSEcCtD
Finasteride—Influenza—Riluzole—amyotrophic lateral sclerosis	0.036	0.0474	CcSEcCtD
Finasteride—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0346	0.0456	CcSEcCtD
Finasteride—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0332	0.0437	CcSEcCtD
Finasteride—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0301	0.0397	CcSEcCtD
Finasteride—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.0289	0.038	CcSEcCtD
Finasteride—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0286	0.0377	CcSEcCtD
Finasteride—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0284	0.0374	CcSEcCtD
Finasteride—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.026	0.0343	CcSEcCtD
Finasteride—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0253	0.0332	CcSEcCtD
Finasteride—Progesterone—SIGMAR1—amyotrophic lateral sclerosis	0.0249	1	CrCbGaD
Finasteride—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0229	0.0302	CcSEcCtD
Finasteride—Infection—Riluzole—amyotrophic lateral sclerosis	0.0204	0.0268	CcSEcCtD
Finasteride—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0191	0.0252	CcSEcCtD
Finasteride—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0183	0.024	CcSEcCtD
Finasteride—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.0182	0.024	CcSEcCtD
Finasteride—Pain—Riluzole—amyotrophic lateral sclerosis	0.0175	0.0231	CcSEcCtD
Finasteride—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.0163	0.0214	CcSEcCtD
Finasteride—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0199	CcSEcCtD
Finasteride—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0193	CcSEcCtD
Finasteride—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0191	CcSEcCtD
Finasteride—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0178	CcSEcCtD
Finasteride—Rash—Riluzole—amyotrophic lateral sclerosis	0.0129	0.017	CcSEcCtD
Finasteride—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0129	0.017	CcSEcCtD
Finasteride—Headache—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0169	CcSEcCtD
Finasteride—AKR1D1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00879	0.0408	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00759	0.0353	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00759	0.0353	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00695	0.0323	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00695	0.0323	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00677	0.0314	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00646	0.03	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00646	0.03	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00619	0.0288	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00607	0.0282	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00607	0.0282	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00576	0.0267	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00541	0.0251	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00416	0.0193	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00416	0.0193	CbGpPWpGaD
Finasteride—AKR1D1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00388	0.018	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00371	0.0172	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00338	0.0157	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00338	0.0157	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00338	0.0157	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00338	0.0157	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00315	0.0146	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00315	0.0146	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00309	0.0144	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00309	0.0144	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00301	0.014	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00301	0.014	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00288	0.0134	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00288	0.0134	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00281	0.0131	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00276	0.0128	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0027	0.0126	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0027	0.0126	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00256	0.0119	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00245	0.0114	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.00245	0.0114	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00241	0.0112	CbGpPWpGaD
Finasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00241	0.0112	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00218	0.0101	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00186	0.00864	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00185	0.00861	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00185	0.00861	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GSR—amyotrophic lateral sclerosis	0.00171	0.00794	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.00171	0.00794	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00165	0.00767	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00156	0.00723	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00156	0.00723	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GSR—amyotrophic lateral sclerosis	0.00152	0.00708	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.0014	0.00652	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.0014	0.00652	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00139	0.00645	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00134	0.00625	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.00128	0.00595	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.00128	0.00595	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00125	0.00581	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.00114	0.00531	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000878	0.00408	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000878	0.00408	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000832	0.00387	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000821	0.00381	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000783	0.00364	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000755	0.00351	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000755	0.00351	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000694	0.00322	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000694	0.00322	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000673	0.00312	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000638	0.00296	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000638	0.00296	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000625	0.0029	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000618	0.00287	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000602	0.00279	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000593	0.00276	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000583	0.00271	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000571	0.00265	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000571	0.00265	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000542	0.00252	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00051	0.00237	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000509	0.00236	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000461	0.00214	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000461	0.00214	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000461	0.00214	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000422	0.00196	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000392	0.00182	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000391	0.00182	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000391	0.00182	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000369	0.00171	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000349	0.00162	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000349	0.00162	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	0.000333	0.00155	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000322	0.0015	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00028	0.0013	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000276	0.00128	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000265	0.00123	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000253	0.00117	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000233	0.00108	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000214	0.000996	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000214	0.000996	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000196	0.000911	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000191	0.000889	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000182	0.000847	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000171	0.000796	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000155	0.00072	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000142	0.000661	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000131	0.000608	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000117	0.000546	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000108	0.000503	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	0.000108	0.0005	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000103	0.000478	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.45e-05	0.000439	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	8.9e-05	0.000413	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	7.78e-05	0.000361	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.37e-05	0.000343	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.33e-05	0.000248	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.78e-05	0.000222	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.4e-05	0.000204	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.62e-05	0.000168	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.48e-05	0.000115	CbGpPWpGaD
